InvestorsHub Logo
Join InvestorsHub

Join the InvestorsHub Community

Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.

Live Updating
profile icon
whytestocks Free
10/02/20 10:54 PM
profile icon
whytestocks Free
10/02/20 4:00 PM
profile icon
Stocker1981 Free
10/27/14 1:34 PM
profile icon
locksflooring Free
01/24/12 6:16 PM
profile icon
MinnieM Free
01/23/12 4:29 AM
profile icon
MikeInTucson Free
01/20/12 3:02 PM
profile icon
Nabbbss Free
01/20/12 11:35 AM
profile icon
DHANA Free
01/06/12 9:40 AM
profile icon
locksflooring Free
01/04/12 9:27 PM
profile icon
locksflooring Free
12/24/11 11:02 PM
profile icon
locksflooring Free
12/06/11 7:50 PM
profile icon
locksflooring Free
12/06/11 7:49 PM
profile icon
locksflooring Free
11/23/11 6:34 AM
profile icon
Aduke Grandfathered
11/07/11 12:34 PM
profile icon
DHANA Free
11/07/11 12:29 PM
profile icon
Aduke Grandfathered
11/07/11 12:12 PM
profile icon
Aduke Grandfathered
11/04/11 12:05 PM
profile icon
locksflooring Free
10/29/11 10:30 AM
profile icon
MikeInTucson Free
09/07/11 12:04 AM
profile icon
locksflooring Free
09/06/11 7:49 PM
profile icon
MinnieM Free
09/06/11 1:39 PM
profile icon
MinnieM Free
09/05/11 9:14 PM
profile icon
locksflooring Free
09/05/11 7:32 AM
profile icon
MinnieM Free
09/01/11 7:50 PM
profile icon
locksflooring Free
08/29/11 9:59 PM
profile icon
Atlanta1 Free
08/18/11 4:58 PM
profile icon
locksflooring Free
08/18/11 4:53 PM
profile icon
MinnieM Free
08/14/11 2:24 PM
profile icon
MikeInTucson Free
08/14/11 1:04 AM
profile icon
ospreyeye Free
08/13/11 2:28 PM
profile icon
ospreyeye Free
08/13/11 2:22 PM
profile icon
locksflooring Free
08/11/11 9:42 PM
profile icon
AntiMarketMaker Free
08/06/11 10:00 AM
profile icon
MikeInTucson Free
08/03/11 2:36 PM
profile icon
locksflooring Free
08/01/11 9:37 PM
profile icon
MikeInTucson Free
08/01/11 1:18 PM
profile icon
Cousinrolf Free
08/01/11 11:10 AM
profile icon
MikeInTucson Free
07/31/11 10:25 PM
profile icon
locksflooring Free
07/31/11 6:18 PM

AmStem Corporation (fka AMST) RSS Feed

Followers
29
Posters
157
Posts (Today)
0
Posts (Total)
4024
Created
08/25/00
Type
Free
Moderators

 

AmStem Corporation (AMST)


formerly Stem Cell Therapy International, Inc. (SCII)




 

Warning!!! 

iBox may have incorrect data due to major changes in company status. 

Will update ASAP.


 

Keep in mind that moderators may or may not have a position in said stock. 
Being a moderator isn't a sign of endorsement.

 



 

AmStem Corporation

Formerly known as Stem Cell Therapy International, Inc.   

The company appears to be a shell that is now 60% owned by Histostem  http://www.histostem.co.kr/english/english_1.htm

The hope for shareholders is that Histostem brings product to the US market via this shell.

 

 


 

 

 

 


 



CIK:  0001360479

 

  • The development of other products by Histostem's accomplished team of scientists, and/or acquisition of similar, supporting lines of products from other companies is a major objective.


Proven Stem Cell Facial Cream

 



 

 


 


High-Tech Cord Blood Banking

  • AmStem will make inroads to link up Histostem's vast repository of genetically desirable Cord Blood Units (CBUs) with other international networks that provide HLA-typed cord blood samples directly to physicians for the off-label treatment of their patients. A new European Patent was recently awarded to support this.
  • These high-quality CBUs, monitored and quality-controlled by a state-of-the-art cryopreservation system, will also be made available to researchers at major hospitals and universities around the world. Two recent hospitals have recently opened the gateway to the vast Chinese medical market by awarding a contract to Histostem.
  • Histostem was recently granted a new US Patent for their proprietary method on deriving the maximum number of viable stem cells from a frozen cord blood specimen. This gives AmStem a strategic advantage in controlling one of the most efficient and non-controversial supply chain, storage, and delivery systems for stem cells in the world.

Histostem Cord Blood Storage

 


Exciting New Treatments

  • AmStem will be generating and monitoring new, improved Clinical Trials to validate and build upon the early successes of Histostem, which has an established pipeline of promising treatments that have already been tested on real patients, including many that are patented in Korea.
  • AmStem will focus on developing a novel Hair Restoration clinical trial, using a method that has already been applied for, and is imminently pending a major U.S. Patent.
  • Histostem is the only company in the world to have full KFDA approval to use its cord blood derived stem cells directly for the treatment of disease. Clinical trials have been in progress for over 2 years to treat intractable conditions such as Buerger's Disease, Alzheimer's and Liver Cirrhosis, as well as Diabetes Mellitus, Hair Restoration and ALS.


Clinical Trials:  Stem Cell Treatments for Incurable Disease

Histostem Ltd. of South Korea, has enjoyed a unique position in the world of stem cell research for a number of years. In February 2007, they received approval from the Korean FDA to use stem cells as a "surgical technique" to treat virtually any emergency condition.

Buoyed by this unprecedented regulatory support, Dr. Hoon Han of Histostem has partnered with leading researchers at the finest hospitals and universities in Korea, to study the treatment of intractable disease using non-controversial stem cells derived from umbilical cord blood. While using his patented techniques to prepare and treat patients, Dr. Han and his research team have compiled a significant body of research data that is unique in the world.

The initial data shows some exciting successes, and AmStem will be validating these early results with controlled clinical trials designed to the highest international (ICH) standards.

 
 

Management Team:   http://www.amsteminc.com/about-amstem/management-team

 

Dr. Han Hoon, M.D., PhD

President of Histostem Korea.

Internationally recognized scientist in stem cell and regenerative treatment

 
Histostem Lab


 

Patents Registered & Pending by Histostem http://amsteminc.com/technology/patents  

 


Press Releases: 

http://amsteminc.com/investor-relations/press-releases

 

http://finance.yahoo.com/q/h?s=AMST.PK

 

Histostem Press Releases:

07/07/05 South Korean medical firm offers stem cell treatment to foreigners

03/22/05 AFP 'Seoul blood bank freezes assets for breakthrough cell therapy'

11/26/04 The Korea Times 'Korean Scientists Succeeded in Stem Cell Therapy'

 

 

Filings:

http://sec.gov/cgi-bin/browse-edgar?CIK=0001360479&action=getcompany


Fiscal year ends March 31
 

 

Transfer Agent:

Standard Transter & Trust Co., Inc.
2980 S Rainbow Blvd.
Suite 120

Las Vegas, NV89146
Office (702) 987-1328 
Fax (866) 801-4192 

 

 

   

Share Structure:

Coming

 

Investor Relations:

http://www.hawkassociates.com/clients/

Hawk Associates

Tom Fox

(305) 451-1888

amstem@hawkassociates.com
 
 

 

 

 

All messages, including iBox content, are the opinion of the posters, are no substitute for your own research, and should not be relied upon for stock trading or any other purpose.

 

Also, keep in mind that moderators may or may not have a position in said stock.  Being a moderator isn't a sign of endorsement.

 

Please keep your posts on topic because your message(s) will probably be deleted when:
* Posting content that's off-topic to the subject of this board;
* Posting statements that don't add value to the discussion; or
* When you violate any other posting term of the iHub User Agreement:
http://investorshub.advfn.com/boards/complex_terms.asp

 

Board Info
Posts Today
0
Posts (Total)
4024
Posters
157
Moderators
New Post